-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Videos|October 21, 2022

Enfortumab Vedotin (EV) Monotherapy and Pembrolizumab (P) Combination Treatments in Urothelial Cancer

Arlene Siefker-Radtke, MD, opens a discussion recapping the ESMO 2022 conference surrounding advanced and metastatic urothelial cancer.

Episodes in this series

EP. 1 Enfortumab Vedotin (EV) Monotherapy and Pembrolizumab (P) Combination Treatments in Urothelial Cancer

EP. 1 Enfortumab Vedotin (EV) Monotherapy and Pembrolizumab (P) Combination Treatments in Urothelial Cancer

EP. 2 Unmet Needs of Patients with Locally Advanced Metastatic Urothelial Cancer (mUC)

EP. 2 Unmet Needs of Patients with Locally Advanced Metastatic Urothelial Cancer (mUC)

EP. 3 EV+P Combination Strategy Changing Bladder Cancer Treatment Landscape

EP. 3 EV+P Combination Strategy Changing Bladder Cancer Treatment Landscape

EP. 4 SOGUG-AUREA Study Overview

EP. 4 SOGUG-AUREA Study Overview

EP. 5 SOGUG-AUREA Trial Results Impacting Next-Steps for Bladder Cancer Treatment

EP. 5 SOGUG-AUREA Trial Results Impacting Next-Steps for Bladder Cancer Treatment

EP. 6 Exploring the Role of Disitamab Vedotin in the Treatment of Metastatic Urothelial Cancer

EP. 6 Exploring the Role of Disitamab Vedotin in the Treatment of Metastatic Urothelial Cancer

EP. 7 Penpulimab Plus Anlotinib Evaluated for Previously Treated Urothelial Cancers

EP. 7 Penpulimab Plus Anlotinib Evaluated for Previously Treated Urothelial Cancers

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Dr Amandeep Salhotra | Image Credit: City of Hope

AGAVE-201 Secondary Analysis Supports Bone Health Safety of Axatilimab in Chronic GVHD: Amandeep Salhotra, MD

ByBrooke McCormick,Amandeep Salhotra

July 7th 2026

Image credit: JCP-PROD - stock.adobe.com

Hypoglossal Nerve Stimulation Linked to Reduced Hypoxic Burden in OSA

ByGiuliana Grossi

July 7th 2026

Experts featured in this series.

Fixing the Mental Health System: Burnout, Advocacy, and the Case for Team-Based Care

ByPatrick Runnels, MD, MBA,Ginger Shupe, MD,Gus Alva, MD, DFAPA,Joe Goldberg, MD

Published: July 7th 2026 | Updated: June 16th 2026

Experts featured in this series.

The Ripple Effect of Coverage Delays: Patient Harm and Preventable Crises in Psychiatry

ByPatrick Runnels, MD, MBA,Ginger Shupe, MD,Gus Alva, MD, DFAPA,Joe Goldberg, MD

Published: July 7th 2026 | Updated: June 16th 2026

Flue vaccine. | @Leigh Prather.jpeg

FDA Advisory Committee Supports Moderna mRNA Flu Vaccine Review

BySabrina McCrear

July 6th 2026

Trending on AJMC

Medicare GLP-1 Bridge Launches, but Who Actually Qualifies?

FDA Advisory Committee Supports Moderna mRNA Flu Vaccine Review

340B Drug Payment Cuts Headline CMS Proposal to Lower Medicare Costs

FDA Approves Atacicept for IgA Nephropathy

Online GLP-1 Sellers Often Skip Clinician Oversight